This study is actively recruiting.

Description: Join a Clinical Research Study. For adolescents 12 to 16 years old diagnosed with schizophrenia

Seven visits conveniently scheduled at Kennedy Krieger Institute over 10 weeks

Each visit lasts from 2 to 3 hours

There is compensation for time and travel for each visit

The purpose of the study is to determine if study drug Na-Ben (sodium benzoate), added on to existing treatment, is safe and effective.

Eligibility & Criteria

IRB # 00030540

Principal Investigator: Robert Findling, MD, MBS

Study Sponsor: SyneuRX International (Taiwan) Corp.

Eligible Age Range:12 – 16 years  

Gender: All

Diagnosis:  Schizophrenia

Contact:  To learn more, call the Clinical Trials Unit: Kennedy Krieger Institute—(443) 923-3850


Keyword:  schizophrenia

Click here to view study flyer.